FDA全球物质注册数据库（FDA Global Substance Registration System）
物质名称5-((7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)AMINO)-2-OXO-PENTANOIC ACID
异名/同义词5-((7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)AMINO)-2-OXO-PENTANOIC ACID
LINAGLIPTIN METABOLITE M504(2)
PENTANOIC ACID, 5-((7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)AMINO)-2-OXO-
CAS登记号1807607-25-5
物质唯一标识(Unique Ingredient Identifier)JVN6L30QZK
分子式
国际化合物标识(International Chemical Identifier,InChI)C25H25N7O5
SMILESFNDUYVQCZRSNAY-UHFFFAOYSA-N
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型c1cc2c(c(nc(n2)Cn3c(=O)n(C)c4c(c3=O)n(c(n4)NCCCC(C(O)=O)=O)CC#CC)C)cc1 / INGREDIENT SUBSTANCE
关联数据
    扩展资源
    ©2006-2026 Drugfuture->FDA Global Substance Registration System